SPIRIT 2013 statement: Defining standard protocol items for clinical trials

An Wen Chan; Jennifer M. Tetzlaff; Douglas G. Altman; Andreas Laupacis; Peter C. Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A. Berlin; Caroline J. Doré; Wendy R. Parulekar; William S.M. Summerskill; Trish Groves; Kenneth F. Schulz; Harold C. Sox; Frank W. Rockhold; Mmond Rennie; David Moher

SPIRIT 2013 statement: Defining standard protocol items for clinical trials

An Wen Chan, Jennifer M. Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C. Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A. Berlin, Caroline J. Doré, Wendy R. Parulekar, William S.M. Summerskill, Trish Groves, Kenneth F. Schulz, Harold C. Sox, Frank W. Rockhold, Mmond Rennie, David Moher

Bloomberg School of Public Health

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1895-1904
Number of pages	10
Journal	Japanese Pharmacology and Therapeutics
Volume	45
Issue number	12
State	Published - 2017

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Cite this

Chan, A. W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., Doré, C. J., Parulekar, W. R., Summerskill, W. S. M., Groves, T., Schulz, K. F., Sox, H. C., Rockhold, F. W., Rennie, M., & Moher, D. (2017). SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Japanese Pharmacology and Therapeutics, 45(12), 1895-1904.

Chan, AW, Tetzlaff, JM, Altman, DG, Laupacis, A, Gøtzsche, PC, Krleža-Jerić, K, Hróbjartsson, A, Mann, H, Dickersin, K, Berlin, JA, Doré, CJ, Parulekar, WR, Summerskill, WSM, Groves, T, Schulz, KF, Sox, HC, Rockhold, FW, Rennie, M & Moher, D 2017, 'SPIRIT 2013 statement: Defining standard protocol items for clinical trials', Japanese Pharmacology and Therapeutics, vol. 45, no. 12, pp. 1895-1904.

@article{55cdca5e044146438cd6557b33366842,

title = "SPIRIT 2013 statement: Defining standard protocol items for clinical trials",

author = "Chan, {An Wen} and Tetzlaff, {Jennifer M.} and Altman, {Douglas G.} and Andreas Laupacis and G{\o}tzsche, {Peter C.} and Karmela Krle{\v z}a-Jeri{\'c} and Asbj{\o}rn Hr{\'o}bjartsson and Howard Mann and Kay Dickersin and Berlin, {Jesse A.} and Dor{\'e}, {Caroline J.} and Parulekar, {Wendy R.} and Summerskill, {William S.M.} and Trish Groves and Schulz, {Kenneth F.} and Sox, {Harold C.} and Rockhold, {Frank W.} and Mmond Rennie and David Moher",

year = "2017",

language = "English (US)",

volume = "45",

pages = "1895--1904",

journal = "Japanese Pharmacology and Therapeutics",

issn = "0386-3603",

publisher = "Life Science Publishing Co. Ltd",

number = "12",

}

TY - JOUR

T1 - SPIRIT 2013 statement

T2 - Defining standard protocol items for clinical trials

AU - Chan, An Wen

AU - Tetzlaff, Jennifer M.

AU - Altman, Douglas G.

AU - Laupacis, Andreas

AU - Gøtzsche, Peter C.

AU - Krleža-Jerić, Karmela

AU - Hróbjartsson, Asbjørn

AU - Mann, Howard

AU - Dickersin, Kay

AU - Berlin, Jesse A.

AU - Doré, Caroline J.

AU - Parulekar, Wendy R.

AU - Summerskill, William S.M.

AU - Groves, Trish

AU - Schulz, Kenneth F.

AU - Sox, Harold C.

AU - Rockhold, Frank W.

AU - Rennie, Mmond

AU - Moher, David

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85042534380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042534380&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:85042534380

SN - 0386-3603

VL - 45

SP - 1895

EP - 1904

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

IS - 12

ER -

SPIRIT 2013 statement: Defining standard protocol items for clinical trials

ASJC Scopus subject areas

Other files and links

Cite this